An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Frequency Therapeutics, Inc. (NASDAQ: FREQ) announced that interim CEO Christopher Loose, Ph.D., will present at two major healthcare investor conferences in March. He will participate in a panel at the 43rd Annual Cowen Healthcare Conference on March 8 at 12:50 p.m. ET and provide a company overview at the 33rd Annual Oppenheimer Healthcare Conference on March 13 at 8:00 a.m. ET. Live webcasts of these events will be available on the company’s website, with replays posted afterward. Frequency Therapeutics focuses on regenerative medicine aimed at restoring human function through the activation of progenitor cells, particularly targeting potential therapies for multiple sclerosis.
Positive
None.
Negative
None.
LEXINGTON, Mass.--(BUSINESS WIRE)--
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced that interim Chief Executive Officer and Chief Scientific Officer Christopher Loose, Ph.D., will present at the following March healthcare investor conferences:
43rd Annual Cowen Healthcare Conference: Dr. Loose will participate on a panel discussion on March 8th at 12:50 p.m. ET.
33rd Annual Oppenheimer (Virtual) Healthcare Conference:Dr. Loose will provide a Company overview on Monday March 13th at 8:00 a.m. ET.
Live conference webcasts can be accessed on the Investors and Media section of the Company’s website, investors.frequencytx.com. A replay will be posted following each event.
About Frequency Therapeutics
Headquartered in Lexington, Mass., Frequency Therapeutics is pioneering a new category in regenerative medicine that aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body through the activation of progenitor cells. The Company’s lead preclinical program is designed to activate oligodendrocyte precursor cells with the goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis. For more information, visit www.frequencytx.com and follow Frequency on Twitter @Frequencytx.
